pelacarsen (AKCEA-APO(a)-LRx) - Novartis
Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3-Now What? (PubMed, JAMA) - Oct 17, 2026 - No abstract available 
Journal • P3 data
http://www.ncbi.nlm.nih.gov/pubmed/42886494
 
Jennifer Abbasi
 
Oct 17, 2026
 
Prev Next